Search Results
Active Site Polymerase Inhibitor Nucleotides (APSINs) - D. Mayers, MD
Core Inhibitors (Capsid Assembly Modulators) - L. Stamm, MD, PhD
New Combination Therapies in Hepatitis Delta Therapy - J. Glenn, MD, PhD
How to Handle Flares in HBV Trials With Novel Agents - H. Janssen, MD, PhD
HBsAg Loss: A Predictor of Long-Term Clinical Outcomes - M. Peters, MD
Safety Monitoring during HBV Clinical Trials and after Antiviral Discontinuation -P. Mishra, MD
ICE HBV panel
High level Panel Roundtable - AIDSImpact Webinar 3
Industry Discussion on Combination Therapy for Hepatitis B Cure at ICE HBV Toronto Symposium